DBS just became the first Singapore stock to cross S$200 billion, yet the income case for a fresh buyer at today’s prices is more fragile than the headline suggests. In this episode I walk Angela through why Citi can lift targets on all three local banks and still keep UOB at neutral, and why that cautious stance quietly lines up with my own wait and see on the sector. We then zoom out to the week’s pullback in STI names, from SIA and Keppel to YZJ, and connect it to Singapore’s latest GDP print where Middle East tensions finally show up in hard numbers instead of just market chatter. If you are building retirement cashflow from CPF and SRS, this is a walkthrough of why record bank valuations and solid balance sheets do not automatically clear your 4.7% yield hurdle today.
Key takeaways:
DBS crosses S$200 billion market cap, first Singapore listed company to do it.
Citi lifts target prices on DBS, OCBC and UOB, but keeps UOB at neutral.
STI slips about 0.6 per cent as cyclicals like YZJ, Keppel and SIA see 1 to 2 per cent red days.
Singapore’s GDP growth cools from around mid 6 per cent to the mid 5 per cent range as Middle East tensions weigh on exports.
COE premiums for commercial vehicles hit a fresh record, adding cost pressure for small businesses on top of regular car COEs.
Iggy’s Forensic Disclaimer
This content is produced for educational and informational purposes only. I am not a financial advisor — I am a retail investor who applies forensic analysis to my own portfolio and shares that process publicly. Nothing here constitutes a recommendation to buy, sell, or hold any security, and no specific target prices or personalised financial advice are offered. Stocks assessed under Iggy’s Forensic Yield Standard are benchmarked against a 4.7% minimum yield hurdle; stocks flagged as Growth Watch fall below this threshold but demonstrate clean balance sheet metrics and an identifiable growth catalyst — these carry a materially different risk profile and are not suitable as yield replacements for income-dependent investors. All data is sourced from public filings and verified sources; where data is unverified it is explicitly flagged. All investments carry risk, including the potential loss of principal, and past performance is not indicative of future results. If you are making investment decisions involving CPF, SRS, or personal capital, please conduct your own due diligence or consult a MAS-licensed financial adviser before committing funds.
